Drug
Rly 5836
Rly 5836: highest development phase Phase 1, developed by Relay Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Relay Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| RLY-5836 NCT05759949 | Phase 1 | PIK3CA Mutation |
Latest
No recent events.
Follow Rly 5836 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.